compounded semaglutide crackdown news today Drugmakers battle pharmacies over Ozempic and Zepbound : Shots Hims is in the crosshairs.

Compounded retatrutide from a licensed pharmacy is manufactured under regulatory oversight, but it has not undergone FDA review for safety and efficacy

Although hair loss isnt an officially listed side effect of GLP-1 drugs a class of medications used to treat obesity and type 2 diabetes, including Wegovy, Ozempic, and Zepbound anecdotal reports and emerging research suggest that its a real phenomenon

Participants are usually adults with obesity or significant metabolic disease, often with additional criteria such as insulin resistance or cardiovascular risk factors

"It's not willpower," he says

Strong trial data has pushed more people into search mode

Sign up to get our biotech newsletter in your inbox